Paradoxical High-Density Lipoprotein Reduction Induced by Fenofibrate and Ciprofibrate
Author:
Affiliation:
1. Department of Chemical Pathology, Thornton Heath, Surrey CR7 7YE, UK
2. Department of Cardiology, Mayday University Hospital, Thornton Heath, Surrey CR7 7YE, UK
Publisher
SAGE Publications
Subject
Clinical Biochemistry,General Medicine
Link
http://journals.sagepub.com/doi/pdf/10.1177/000456329603300213
Reference7 articles.
1. Lower patients' cholesterol now
2. Comparative Efficacy and Safety of Micronized Fenofibrate and Simvastatin in Patients With Primary Type Ha or IIb Hyperlipidemia
3. Progression and regression of minor coronary arterial narrowings by quantitative angiography after fenofibrate therapy
4. Ciprofibrate and lipid profile
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Paradoxical and Bidirectional Drug Effects;Drug Safety;2012-01
2. Paradoxical decrease in serum high-density lipoprotein cholesterol and lipid-lowering drugs;Annals of Clinical Biochemistry: International Journal of Laboratory Medicine;2011-01
3. Low incidence of paradoxical reductions in HDL-C levels in dyslipidemic patients treated with fenofibrate alone or in combination with ezetimibe or ezetimibe/simvastatin;Lipids in Health and Disease;2011
4. HDL Cholesterol Reduction during Rosiglitazone and Fenofibrate Treatment in a Type 2 Diabetes Mellitus Patient with Dyslipidemia;Annals of Laboratory Medicine;2010-02-01
5. Iatrogenic Severe Depression of High-Density Lipoprotein Cholesterol;The Journal of Clinical Pharmacology;2009-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3